An Moonen - Nyxoah General Counsel

NYXH Stock  USD 8.28  0.07  0.85%   

Executive

An Moonen is General Counsel of Nyxoah
Address Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium, 1435
Phone32 10 22 23 55
Webhttps://www.nyxoah.com

Nyxoah Management Efficiency

The company has return on total asset (ROA) of (0.2314) % which means that it has lost $0.2314 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4969) %, meaning that it created substantial loss on money invested by shareholders. Nyxoah's management efficiency ratios could be used to measure how well Nyxoah manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.37. The current Return On Capital Employed is estimated to decrease to -0.43. As of now, Nyxoah's Other Assets are increasing as compared to previous years. The Nyxoah's current Other Current Assets is estimated to increase to about 4.8 M, while Total Assets are projected to decrease to under 94.2 M.
Nyxoah currently holds 12.7 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Nyxoah has a current ratio of 7.1, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Nyxoah's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 7 records

EXECUTIVE Age

Gregory RobbNexgel Inc
N/A
Juan DiazCartelleMicrobot Medical
48
Corey GibbsAvinger
N/A
Ben ScheuSharps Technology
N/A
Himanshu PatelAvinger
64
MD FACCAvinger
N/A
Nabeel SubainatiAvinger
40
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Nyxoah S is traded on NASDAQ Exchange in the United States. Nyxoah (NYXH) is traded on NASDAQ Exchange in USA. It is located in Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium, 1435 and employs 146 people. Nyxoah is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Nyxoah Leadership Team

Elected by the shareholders, the Nyxoah's board of directors comprises two types of representatives: Nyxoah inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nyxoah. The board's role is to monitor Nyxoah's management team and ensure that shareholders' interests are well served. Nyxoah's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nyxoah's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeremy Feffer, VP Communication
Dorit Nahari, VP Operations
An Moonen, General Counsel
John Landry, Chief Officer
Inge Vanwittenbergh, Global Director
Francis Kim, Chief Officer
Mikaela Kirkwood, Corporate Manager
Loic Moreau, President International
Olivier Taelman, CEO Director
Remi Renard, Vice Access
David DeMartino, Chief Officer
Robert MBA, CoFounder Chairman
Jeyakumar Subbaroyan, Chief Officer
Bruno Onkelinx, Chief Officer

Nyxoah Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nyxoah a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Nyxoah offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nyxoah's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nyxoah Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nyxoah Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nyxoah. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nyxoah. If investors know Nyxoah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nyxoah listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.83)
Revenue Per Share
0.166
Quarterly Revenue Growth
0.297
Return On Assets
(0.23)
Return On Equity
(0.50)
The market value of Nyxoah is measured differently than its book value, which is the value of Nyxoah that is recorded on the company's balance sheet. Investors also form their own opinion of Nyxoah's value that differs from its market value or its book value, called intrinsic value, which is Nyxoah's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nyxoah's market value can be influenced by many factors that don't directly affect Nyxoah's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nyxoah's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nyxoah is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nyxoah's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.